Travere Therapeutics
TVTX
TVTX
121 hedge funds and large institutions have $769M invested in Travere Therapeutics in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 41 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 126 → 121 (-5)
12% less capital invested
Capital invested by funds: $875M → $769M (-$106M)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
Holders
121
Holding in Top 10
7
Calls
$20.4M
Puts
$4.14M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$12.5M | |
| 3 | +$11.6M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$5.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.96M |
Top Sellers
| 1 | -$6.26M | |
| 2 | -$5.92M | |
| 3 | -$5.59M | |
| 4 |
Morgan Stanley
New York
|
-$4.83M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$4.48M |